Citigroup Inc. Buys 56,507 Shares of BrightSpring Health Services, Inc. $BTSG

Citigroup Inc. lifted its stake in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 42.2% in the third quarter, according to its most recent filing with the SEC. The fund owned 190,357 shares of the company’s stock after acquiring an additional 56,507 shares during the period. Citigroup Inc. owned approximately 0.11% of BrightSpring Health Services worth $5,627,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in BTSG. Lisanti Capital Growth LLC purchased a new position in shares of BrightSpring Health Services during the third quarter worth approximately $1,959,000. Federated Hermes Inc. raised its position in BrightSpring Health Services by 44.8% in the 3rd quarter. Federated Hermes Inc. now owns 319,200 shares of the company’s stock worth $9,436,000 after purchasing an additional 98,745 shares during the period. Prescott Group Capital Management L.L.C. bought a new stake in BrightSpring Health Services in the third quarter worth $887,000. Ellsworth Advisors LLC bought a new stake in BrightSpring Health Services in the third quarter worth $983,000. Finally, Bailard Inc. purchased a new stake in BrightSpring Health Services during the third quarter valued at about $378,000.

BrightSpring Health Services News Roundup

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Mizuho raised its price target on BTSG from $45 to $50 and maintained an “outperform” rating, signaling stronger analyst confidence and a material upside to current levels. Article Title
• Positive Sentiment: Wells Fargo boosted its price target from $43 to $50 and assigned an “overweight” rating, reinforcing the bullish analyst view and likely supporting demand at current prices. Article Title
• Neutral Sentiment: A Zacks comparison piece examines BTSG versus peer Caris Life Sciences (CAI) for value-oriented investors; this is a general research/idea piece rather than a company-specific catalyst. BTSG vs. CAI: Which Stock Is the Better Value Option?
• Neutral Sentiment: Company press releases announce a concurrent share repurchase alongside the planned secondary sale; management intends buyback activity, but details/timing relative to the secondary sale are unclear. BrightSpring Announces Secondary Offering of Common Stock and Concurrent Share Repurchase
• Neutral Sentiment: Short-interest data reported for early March appears internally inconsistent (zeros and NaN values) and is likely a reporting error — it does not provide a meaningful signal to explain today’s move.
• Negative Sentiment: Selling stockholders priced a large secondary offering of 20,000,000 shares at $41.15 per share; BrightSpring is not selling any new shares and selling stockholders receive the proceeds. The size (20M shares) versus typical daily turnover can increase supply pressure and likely weighed on the stock today. BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase

BrightSpring Health Services Price Performance

BTSG opened at $40.65 on Wednesday. The company has a debt-to-equity ratio of 1.32, a quick ratio of 1.12 and a current ratio of 1.57. The stock has a market capitalization of $7.87 billion, a PE ratio of 46.19, a price-to-earnings-growth ratio of 0.65 and a beta of 2.31. The stock’s 50 day moving average price is $39.26 and its 200-day moving average price is $33.67. BrightSpring Health Services, Inc. has a 52-week low of $15.48 and a 52-week high of $44.87.

BrightSpring Health Services (NASDAQ:BTSG) last released its quarterly earnings results on Friday, February 27th. The company reported $0.33 earnings per share for the quarter, missing the consensus estimate of $0.34 by ($0.01). BrightSpring Health Services had a net margin of 1.48% and a return on equity of 12.66%. The company had revenue of $3.55 billion during the quarter, compared to the consensus estimate of $3.38 billion. During the same quarter last year, the firm earned $0.11 EPS. The business’s revenue was up 29.3% on a year-over-year basis. On average, equities research analysts predict that BrightSpring Health Services, Inc. will post 0.59 EPS for the current year.

Wall Street Analysts Forecast Growth

BTSG has been the topic of several analyst reports. Zacks Research downgraded BrightSpring Health Services from a “strong-buy” rating to a “hold” rating in a report on Tuesday, January 6th. Bank of America lifted their price target on BrightSpring Health Services from $38.00 to $41.00 and gave the stock a “buy” rating in a research note on Tuesday, December 9th. Weiss Ratings reissued a “hold (c)” rating on shares of BrightSpring Health Services in a research note on Monday, December 29th. TD Cowen restated a “buy” rating on shares of BrightSpring Health Services in a report on Monday. Finally, Cantor Fitzgerald set a $49.00 price target on shares of BrightSpring Health Services in a report on Monday. One research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, BrightSpring Health Services has an average rating of “Moderate Buy” and a consensus price target of $42.85.

About BrightSpring Health Services

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.